Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
AEBi
AEBi Overview
Accelerated Evolution Biotechnologies (AEBi) is a development-stage biopharmaceutical company engaged in the discovery and development of therapeutic peptides.
The company has developed an IP-protected combinatorial biology screening platform technology that can be used to find binders to known targets and select the best functional molecules among them. AEBis platform is extremely flexible, harnessing combinatorial biology to discover new and better lead compounds to disease targets.
AEBi was incorporated at the Weizmann Institutes ITEK technological incubator in Nes-Tziona, Israel. The company has a collaboration agreement with Israeli biopharmaceutical company Proteologics.